Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.

Wong, I.C.K., Asherson, P., Bilbow, A., Clifford, S., Coghill, D., DeSoysa, R., Hollis, C., McCarthy, S., Murray, M.L., Planner, C., Potts, L., Sayal, K. and Taylor, E. (2009) Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technology Assessment , 13 (50). pp. 1-144. 10.3310/hta13500.

Full text not available from this repository.

Official URL: http://www.hta.ac.uk/fullmono/mon1350.pdf

DOI: 10.3310/hta13500

Abstract

Part 1 study demonstrated that the prevalence of prescribing by GPs to patients with ADHD dropped significantly from age 15 to 21. The fall in prescribing was greater than the reported age-related decrease in symptoms, raising the possibility that treatment is prematurely discontinued in some young adults where ADHD symptoms persist. Part 2 of the study identified that some young adults had difficulty in obtaining treatment after discharge from paediatric services. Future work should include randomised placebo-controlled trials into long-term treatment with stimulants, particularly methylphenidate.

Item Type:Article
Additional Information:NIHR Health Technology Assessment programme
Departments, units and centres:Department of Practice and Policy > Centre for Paediatric Pharmacy Research
ID Code:2412
Journal or Publication Title:Health Technology Assessment
Deposited By:Library Staff
Deposited On:04 Nov 2011 12:34
Last Modified:04 Nov 2011 12:34

Repository Staff Only: Item control page

School of Pharmacy Staff Only: Edit a copy to replace this item